Olympus Corporation Consolidated Financial Results for the 2nd Quarter for Fiscal Year 2025

Yasuo Takeuchi
Director, Representative Executive Officer, Executive Chairperson and ESG Officer
Tatsuya Izumi
Executive Officer and Chief Financial Officer
Frank Drewalowski
Executive Officer and Endoscopic Solutions Division Head
Seiji Kuramoto
Executive Officer and Therapeutic Solutions Division Head
Boris Shkolnik
Executive Officer and Chief Quality Officer

PLAY LIST

from the beginning

Consolidated Financial Results for the 2nd Quarter for Fiscal Year 2025

Regarding the Recent Change in Representative Executive Officer and CEO

Key Message2Q (6M) Consolidated Financial Results

Key Accomplishments and Outlook for Elevate Program

Clearance/Approval for Cloud-based AI Endoscopy Devices, a Significant Milestone in the Effort to Launch an Intelligent Endoscopy Ecosystem

Timeline for the Realization of an Intelligent Endoscopy Ecosystem

2Q of Fiscal Year 2025 Consolidated Financial Results

2Q of Fiscal Year 2025 Endoscopic Solutions Division (ESD)

2Q of Fiscal Year 2025 Therapeutic Solutions Division (TSD)

Consolidated Statement of Financial Position

Consolidated Cash Flows

Q&A 1

Q&A 2

Q&A 3

Q&A 4

Q&A 5

Q&A 6

Q&A 7

Q&A 8

Q&A 9

Back
Next

Download